New glasses could help kids see better longer

NCT ID NCT05174780

Completed Disease control Sponsor: Essilor International Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new type of spectacle lens designed to slow the progression of myopia (nearsightedness) in children. 159 kids aged 6 to 12 wore either the test lens or a standard lens. Researchers measured changes in eye length and prescription strength over time to see if the innovative lens was safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: innovative myopia control spectacle lens
What this could lead to: If proven effective, this lens could offer a simple, non-invasive way to slow worsening nearsightedness in children, reducing the need for stronger prescriptions.
What could go wrong: The trial is completed but results are not yet widely published. The effect may be modest, and not all children may benefit equally. Long-term safety and effectiveness beyond the study period are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Illinois College of Optometry

Chicago, Illinois, 60616, United States
Kannarr Eye Care

Pittsburg, Kansas, 66762, United States
Mann Eye Institute

Houston, Texas, 77002, United States
New England College of Optometry

Boston, Massachusetts, 02115, United States
SUNY College of Optometry

New York, New York, 10036, United States
Sabal Eye Care

Longwood, Florida, 32779, United States
Sacco Eye Group

Vestal, New York, 13850, United States
Scripps Poway Optometry

San Diego, California, 92131, United States
UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, 15224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.